Diagnosis of Parkinson's disease based on disease-specific autoantibody profiles in human sera.
Parkinson's disease (PD), hallmarked by a variety of motor disorders and neurological decline, is the second most common neurodegenerative disease worldwide. Currently, no diagnostic test exists to identify sufferers, and physicians must rely on a combination of subjective physical and neurolog...
Guardado en:
Autores principales: | Min Han, Eric Nagele, Cassandra DeMarshall, Nimish Acharya, Robert Nagele |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/820aeca8b17444f0b60b0899a70e8ee2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CLINICAL DIAGNOSTIC VALUE OF AUTOANTIBODIES IN THE DIAGNOSIS OF AUTOIMMUNE LIVER DISEASES
por: V. V. Bazarnyi, et al.
Publicado: (2015) -
α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients.
por: Kiran Yanamandra, et al.
Publicado: (2011) -
Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease.
por: Filip Simunovic, et al.
Publicado: (2010) -
Correlations between autoantibodies and the ATR-FTIR spectra of sera from rheumatoid arthritis patients
por: Katarzyna Durlik-Popińska, et al.
Publicado: (2021) -
Temporal trajectory of biofluid markers in Parkinson’s disease
por: Min Seok Baek, et al.
Publicado: (2021)